Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: spunky71 who wrote (5121)	5/27/1999 12:50:00 PM
From: Peter V	Respond to of 5736

spunky71, thanks for the thoughtful response. If the market for CCSI is $120mm, and they get 30 percent penetration in the first year (that seems high, but I'll go with it), that's only $36mm total revenue, but you have to account for manufacturing, distribution and overhead costs, which I think reduces the revenue to at most 30%, so about $12mm for income. As for the machines, let's assume all 600 NICUs buy one (overestimate, but it may account for your home healthcare and pediatrician offices), at $1500 profit to CCSI (they cost $3000-5000, and CCSI will neither manufacture or distribute, so that figure seems high), profit is only $900K. So for US sales, earnings could be as much as $13 million, at 25x earnings, a share price of $20.96. As for dentristry, I haven't seen any substantive PRs about this (not a surprise), so it's hard for me to begin to estimate the market for it. Is CCSI actively marketing in that area? I think your estimates are too high, but I see where you are going with them. Thanks